CORAL GABLES, FL / ACCESSWIRE / March 11, 2019 / The success of the tech stock market is directly correlated to the operating assumption that tech companies are prepared to meet the rising challenges presently facing society. As consumers, we expect innovative companies in the tech industry to design and manufacture products with our best interests at heart and, in turn, these are typically the companies we choose to invest our time and capital in. As we've seen in the first few months of 2019, the tech sector is booming with the excitement surrounding companies working on advanced technologies meant to take humanity into the future. ParcelPal Technology Inc (PTNYF) (PKG), Plug Power Inc (PLUG), Leap Therapeutics Inc (LPTX) and NantHealth Inc (NH) represent 4 tech stocks on the rise on Monday.
ParcelPal Technology Inc (PTNYF) (PKG) is a technology-driven logistics company purposed with connecting consumers to the goods they love. The Company is determined to regulate its on-demand marketplace where customers can purchase what they need and have their goods delivered within an hour.
ParcelPal Technology Inc (PTNYF) (PKG) announced towards the tail-end of last month that Brian Storseth had joined the Company as Chairman of the Board of Directors. Prior to joining the ParcelPal team, Mr. Storseth was a Member of Parliament for the electoral district of Westlock-St Paul for the Conservative Party of Canada for 9 years from 2006-2015. During his tenure as an MP, he served on committees for Aboriginal Affairs, Agriculture and Agri-food Canada.
Following the announcement, Kelly Abbot, President and CEO of ParcelPal Technology Inc (PTNYF) (PKG) said, ''Brian is an incredibly accomplished business leader and policy expert, having spent 9 years in Ottawa in the House of Commons. He is intimately familiar with ParcelPal's business, our plans for future expansion and will be an invaluable asset moving forward as we navigate multiple opportunities across various Government entities, namely within the Ontario market. We are excited to leverage his network, experience, and leadership to assist with our national expansion plans.''
Plug Power Inc (PLUG), a leader in providing energy solutions that change the way the world moves, last week announced its 2018 fourth quarter and year-end results. Per the details of the announcement, the Company enjoyed a record-setting quarter as a result of technical leadership and continued new product deployment, coupled with constant attention to improving service.
In 2018, the Company delivered the first ProGen-powered delivery van to FedEx at the start of the year - and the vehicle has reportedly covered over 14,000 miles delivering packages since then.
Leap Therapeutics Inc (LPTX), a biotechnology company focused on developing targeted and immunooncology therapeutics, announced last week that the Company will be presenting at the Society of Gynecologic Oncology 2019 Annual Meeting on Women's Cancer, being held March 16-19, 2019 in Honolulu, HI.
As for their presentation, the Company will be showcasing its P204 study, a Phase 2 basket study of DKN-01 as both a monotherapy and in combination with paclitaxel in patients with advanced endometrioid unterine (EEC) and endometrioid ovarian (EOC) cancers. The study consists of four dosing groups and will enroll up to 94 patients using a Simon 2-Stage design in each group.
NantHealth Inc (NH) made headlines back in February when the Company shared details about its presentation of several posters at the American Society of Clinical Oncology's Genitourinary Cancers Symposium later in the month. NantHealth, in partnership with NantOmics, teamed together to explore the significance of RNA expression and individual biomarkers in determining why some patients do not respond to targeted cancer therapies based on DNA genomic profiling alone.
Following their presentation, Sandeep Reddy, Chief Medical Officer of NantHealth, said, ''while next-generation sequencing for advanced cancers has become routine, not all patients are responding to targeted treatments based solely on DNA genomic profiling. It is becoming clear that we must delve deeper into RNA expression, as well as identify key biomarkers, to develop effective cancer treatments and therapies.''
What Is Stock Price (StockPrice.com)?
Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.
StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.
At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
JSG Communications, LLC, which owns www.StockPrice.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
Midam Ventures has been compensated $75,000 per month by a ParcelPal Technology, Inc. for a period beginning September 1, 2018, and ending February 1, 2019, to publicly disseminate information about (PTNYF/PKG) to publicly disseminate information about (PTNYF/PKG). Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to April 1, 2019. We may buy or sell additional shares of (PTNYF/PKG) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares. Please click here for full disclaimer.
View source version on accesswire.com: